Work

P-392 A Phase 1 Trial of 225Actinium-DOTADaratumumab in Patients with Daratumumab-Refractory Multiple Myeloma: Results from First Cohorts

Year: 2024

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)02294-8

Authors: Scott Goldsmith, Vikram Adhikarla, Murali Janakiram, Michael Rosenzweig, Savita Dandapani, Nitya Nathwani, Azra Borogovac, Sarah Lee, Arnab Chowdhury, Jonathan Keats, James Sanchez, Erasmus Poku, Russell Rockne, Paul Yazaki, Jeffrey Wong, John E. Shively, Flavia Pichiorri, Amrita Krishnan

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402734478

Cites:

Cited by:

Related to: 10